LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 58.15 | 27.76 | 5541 | 5906 | 0.9381 | 0.9835 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 58.15 | 27.76 | 5617 | 5906 | 0.9510 | 0.9870 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 58.15 | 27.76 | 1003 | 5906 | 0.1698 | 0.5902 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 58.15 | 27.76 | 7945 | 5906 | 1.3451 | 1.0782 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 59.85 | 27.76 | 5785 | 6062 | 0.9542 | 0.9880 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 59.85 | 27.76 | 5856 | 6062 | 0.9659 | 0.9911 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 59.85 | 27.76 | 1015 | 6062 | 0.1674 | 0.5891 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 59.85 | 27.76 | 8326 | 6062 | 1.3733 | 1.0833 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 61.56 | 27.76 | 6040 | 6217 | 0.9715 | 0.9926 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 61.56 | 27.76 | 6132 | 6217 | 0.9863 | 0.9965 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 61.56 | 27.76 | 1078 | 6217 | 0.1734 | 0.5979 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 61.56 | 27.76 | 8660 | 6217 | 1.3929 | 1.0867 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 63.26 | 27.76 | 6294 | 6465 | 0.9735 | 0.9932 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 63.26 | 27.76 | 6386 | 6465 | 0.9877 | 0.9969 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 63.26 | 27.76 | 1160 | 6465 | 0.1794 | 0.6075 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 63.26 | 27.76 | 9042 | 6465 | 1.3985 | 1.0871 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 64.97 | 27.76 | 6542 | 6656 | 0.9828 | 0.9956 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 64.97 | 27.76 | 6647 | 6656 | 0.9985 | 0.9996 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 64.97 | 27.76 | 1178 | 6656 | 0.1770 | 0.6066 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 64.97 | 27.76 | 9317 | 6656 | 1.3996 | 1.0869 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 66.67 | 27.76 | 6753 | 6695 | 1.0086 | 1.0022 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 66.67 | 27.76 | 6858 | 6695 | 1.0242 | 1.0061 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 66.67 | 27.76 | 1209 | 6695 | 0.1806 | 0.6110 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 66.67 | 27.76 | 9666 | 6695 | 1.4436 | 1.0950 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 68.37 | 27.76 | 6970 | 6879 | 1.0132 | 1.0033 | MN20160318_Q01 | D09 |